MAOA and Parkinson disease: Additionally, GNR-E extract exhibited a stronger inhibitory activity toward monoamine oxidase-B (MAO-B) than monoamine oxidase-A (MAO-A), suggesting its potential relevance to dopaminergic regulation, cognitive impairment and Parkinson’s disease.